Ionis to present at RBC Capital Markets Global Healthcare Conference
Ionis Pharmaceuticals (Nasdaq: IONS), located in Carlsbad, Calif., will present at the RBC Capital Markets Global Healthcare Conference on May 18, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Ionis Pharmaceuticals (Nasdaq: IONS), located in Carlsbad, Calif., will present at the RBC Capital Markets Global Healthcare Conference on May 18, 2022. A live webcast of the presentation will be available on Ionis's website, with a replay accessible within 48 hours after the event. Ionis has over 30 years of experience in RNA-targeted therapy and boasts a strong pipeline focusing on cardiovascular and neurological franchises.
Details
News Market Reaction – IONS
The recorded move for IONS in the trading session of this news was +6.33%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CARLSBAD, Calif., May 12, 2022 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will present at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 18, 2022.
A live webcast and additional information about this presentation can be accessed on the Investors & Media section of the Ionis website at www.ionispharma.com. A replay will be available on the Ionis website within 48 hours of each event.
About Ionis Pharmaceuticals, Inc.
For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming a leading, fully integrated biotechnology company.
To learn more about Ionis visit www.ionispharma.com and follow us on Twitter @ionispharma.
View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-rbc-capital-markets-global-healthcare-conference-301545318.html
SOURCE Ionis Pharmaceuticals, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.